235 related articles for article (PubMed ID: 10583474)
1. 3-Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum.
Guidetti P; Schwarcz R
Eur J Neurosci; 1999 Nov; 11(11):3857-63. PubMed ID: 10583474
[TBL] [Abstract][Full Text] [Related]
2. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
[TBL] [Abstract][Full Text] [Related]
3. Differential action of NMDA antagonists on cholinergic neurotoxicity produced by N-methyl-D-aspartate and quinolinic acid.
Pawley AC; Flesher S; Boegman RJ; Beninger RJ; Jhamandas KH
Br J Pharmacol; 1996 Mar; 117(6):1059-64. PubMed ID: 8882597
[TBL] [Abstract][Full Text] [Related]
4. 3-Hydroxykynurenine and quinolinate: pathogenic synergism in early grade Huntington's disease?
Guidetti P; Schwarcz R
Adv Exp Med Biol; 2003; 527():137-45. PubMed ID: 15206726
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of [5-(3)H]kynurenine in the developing rat brain in vivo: effect of intrastriatal ibotenate injections.
Ceresoli G; Guidetti P; Schwarcz R
Brain Res Dev Brain Res; 1997 May; 100(1):73-81. PubMed ID: 9174248
[TBL] [Abstract][Full Text] [Related]
6. In situ produced 7-chlorokynurenate provides protection against quinolinate- and malonate-induced neurotoxicity in the rat striatum.
Guidetti P; Wu HQ; Schwarcz R
Exp Neurol; 2000 May; 163(1):123-30. PubMed ID: 10785450
[TBL] [Abstract][Full Text] [Related]
7. A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy.
Massieu L; Thedinga KH; McVey M; Fagg GE
Neuroscience; 1993 Aug; 55(4):883-92. PubMed ID: 7694181
[TBL] [Abstract][Full Text] [Related]
8. Dopamine receptor activation reveals a novel, kynurenate-sensitive component of striatal N-methyl-D-aspartate neurotoxicity.
Poeggeler B; Rassoulpour A; Wu HQ; Guidetti P; Roberts RC; Schwarcz R
Neuroscience; 2007 Aug; 148(1):188-97. PubMed ID: 17629627
[TBL] [Abstract][Full Text] [Related]
9. 3-Hydroxykynurenine toxicity on the rat striatum in vivo.
Nakagami Y; Saito H; Katsuki H
Jpn J Pharmacol; 1996 Jun; 71(2):183-6. PubMed ID: 8835646
[TBL] [Abstract][Full Text] [Related]
10. Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid.
Miranda AF; Boegman RJ; Beninger RJ; Jhamandas K
Neuroscience; 1997 Jun; 78(4):967-75. PubMed ID: 9174065
[TBL] [Abstract][Full Text] [Related]
11. Quinolinic acid neurotoxicity: in vivo increased copper and manganese content in rat corpus striatum after quinolinate intrastriatal injection.
Santamaría A; Ríos C; Pérez P; Flores A; Galván-Arzate S; Osorio-Rico L; Solís F
Toxicol Lett; 1996 Oct; 87(2-3):113-9. PubMed ID: 8914619
[TBL] [Abstract][Full Text] [Related]
12. The role of group I and group II metabotropic glutamate receptors in modulation of striatal NMDA and quinolinic acid toxicity.
Orlando LR; Alsdorf SA; Penney JB; Young AB
Exp Neurol; 2001 Jan; 167(1):196-204. PubMed ID: 11161608
[TBL] [Abstract][Full Text] [Related]
13. Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: Implications for Huntington's disease.
Sapko MT; Guidetti P; Yu P; Tagle DA; Pellicciari R; Schwarcz R
Exp Neurol; 2006 Jan; 197(1):31-40. PubMed ID: 16099455
[TBL] [Abstract][Full Text] [Related]
14. Quinolinate potentiates the neurotoxicity of excitatory amino acids in hypoxic neuronal tissue in vitro.
Schurr A; Rigor BM
Brain Res; 1993 Jul; 617(1):76-80. PubMed ID: 8397046
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effects of chronic exposure to subthreshold concentrations of quinolinic acid and malonate in the rat striatum.
Bazzett TJ; Falik RC; Becker JB; Albin RL
Brain Res; 1996 Apr; 718(1-2):228-32. PubMed ID: 8773793
[TBL] [Abstract][Full Text] [Related]
16. Excitotoxic action of NMDA agonists on nigrostriatal dopaminergic neurons: modulation by inhibition of nitric oxide synthesis.
Connop BP; Boegman RJ; Jhamandas K; Beninger RJ
Brain Res; 1995 Apr; 676(1):124-32. PubMed ID: 7540931
[TBL] [Abstract][Full Text] [Related]
17. Dapsone prevents morphological lesions and lipid peroxidation induced by quinolinic acid in rat corpus striatum.
Rodríguez E; Méndez-Armenta M; Villeda-Hernández J; Galván-Arzate S; Barroso-Moguel R; Rodríguez F; Ríos C; Santamaría A
Toxicology; 1999 Nov; 139(1-2):111-8. PubMed ID: 10614692
[TBL] [Abstract][Full Text] [Related]
18. Characterization of striatal cultures with the effect of QUIN and NMDA.
Kumar U
Neurosci Res; 2004 May; 49(1):29-38. PubMed ID: 15099701
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide synthase inhibition prevents acute quinolinate-induced striatal neurotoxicity.
Pérez-Severiano F; Escalante B; Ríos C
Neurochem Res; 1998 Oct; 23(10):1297-302. PubMed ID: 9804286
[TBL] [Abstract][Full Text] [Related]
20. The 1993 Upjohn Award Lecture. Quinolinic acid induced brain neurotransmitter deficits: modulation by endogenous excitotoxin antagonists.
Jhamandas KH; Boegman RJ; Beninger RJ
Can J Physiol Pharmacol; 1994 Dec; 72(12):1473-82. PubMed ID: 7736338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
